• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制定一项规范期刊文章中生物资源引用的指南(CoBRA)。

Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA).

作者信息

Bravo Elena, Calzolari Alessia, De Castro Paola, Mabile Laurence, Napolitani Federica, Rossi Anna Maria, Cambon-Thomsen Anne

出版信息

BMC Med. 2015 Feb 17;13:33. doi: 10.1186/s12916-015-0266-y.

DOI:10.1186/s12916-015-0266-y
PMID:25855867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4331335/
Abstract

BACKGROUND

Many biomedical publications refer to data obtained from collections of biosamples. Sharing such bioresources (biological samples, data, and databases) is paramount for the present governance of research. Recognition of the effort involved in generating, maintaining, and sharing high quality bioresources is poorly organized, which does not encourage sharing. At publication level, the recognition of such resources is often neglected and/or highly heterogeneous. This is a true handicap for the traceability of bioresource use. The aim of this article is to propose, for the first time, a guideline for reporting bioresource use in research articles, named CoBRA: Citation of BioResources in journal Articles.

METHODS

As standards for citing bioresources are still lacking, the members of the journal editors subgroup of the Bioresource Research Impact Factor (BRIF) initiative developed a standardized and appropriate citation scheme for such resources by informing stakeholders about the subject and raising awareness among scientists and in science editors' networks, mapping this topic among other relevant initiatives, promoting actions addressed to stakeholders, launching surveys, and organizing focused workshops.

RESULTS

The European Association of Science Editors has adopted BRIF's suggestion to incorporate statements on biobanks in the Methods section of their guidelines. The BRIF subgroup agreed upon a proposed citation system: each individual bioresource that is used to perform a study and that is mentioned in the Methods section should be cited as an individual "reference [BIORESOURCE]" according to a delineated format. The EQUATOR (Enhancing the QUAlity and Transparency Of health Research) network mentioned the proposed reporting guideline in their "guidelines under development" section.

CONCLUSIONS

Evaluating bioresources' use and impact requires that publications accurately cite such resources. Adopting the standard citation scheme described here will improve the quality of bioresource reporting and will allow their traceability in scientific publications, thus increasing the recognition of bioresources' value and relevance to research. Please see related article: http://dx.doi.org/10.1186/s12916-015-0284-9.

摘要

背景

许多生物医学出版物都提及从生物样本库中获取的数据。对于当前的研究管理而言,共享此类生物资源(生物样本、数据和数据库)至关重要。然而,对于生成、维护和共享高质量生物资源所涉及的努力,目前的认可机制组织不善,这不利于鼓励共享。在出版物层面,对这类资源的认可往往被忽视且/或高度不一致。这对于生物资源使用的可追溯性而言是一个真正的障碍。本文旨在首次提出一项在研究论文中报告生物资源使用情况的指南,即CoBRA:期刊文章中生物资源的引用。

方法

由于目前仍缺乏引用生物资源的标准,生物资源研究影响因子(BRIF)倡议的期刊编辑子组成员通过向利益相关者通报该主题、提高科学家和科学编辑网络中的认识、在其他相关倡议中梳理此主题、推动针对利益相关者的行动、开展调查以及组织专题研讨会,为这类资源制定了一个标准化且合适的引用方案。

结果

欧洲科学编辑协会采纳了BRIF的建议,即在其指南的“方法”部分纳入关于生物样本库的说明。BRIF子组就提议的引用系统达成了一致:在“方法”部分提及的、用于开展研究的每一份单独的生物资源,都应按照规定格式作为单独的“参考文献[生物资源]”进行引用。EQUATOR(提高卫生研究的质量和透明度)网络在其“正在制定的指南”部分提到了提议的报告指南。

结论

评估生物资源的使用和影响需要出版物准确引用此类资源。采用本文所述的标准引用方案将提高生物资源报告的质量,并使其在科学出版物中具有可追溯性,从而提高对生物资源价值及其与研究相关性的认可度。请参阅相关文章:http://dx.doi.org/10.1186/s12916-015-0284-9。

相似文献

1
Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA).制定一项规范期刊文章中生物资源引用的指南(CoBRA)。
BMC Med. 2015 Feb 17;13:33. doi: 10.1186/s12916-015-0266-y.
2
Biobankers: Treat the Poison of Invisibility with CoBRA, a Systematic Way of Citing Bioresources in Journal Articles.生物样本库管理者:用CoBRA(一种在期刊文章中引用生物资源的系统方法)应对无形之毒。
Biopreserv Biobank. 2016 Aug;14(4):350-2. doi: 10.1089/bio.2015.0105. Epub 2016 Jun 17.
3
How to responsibly acknowledge research work in the era of big data and biobanks: ethical aspects of the Bioresource Research Impact Factor (BRIF).在大数据和生物样本库时代如何负责任地认可研究工作:生物资源研究影响因子(BRIF)的伦理问题。
J Community Genet. 2018 Apr;9(2):169-176. doi: 10.1007/s12687-017-0332-6. Epub 2017 Sep 25.
4
Quantifying the use of bioresources for promoting their sharing in scientific research.量化生物资源的使用,以促进其在科学研究中的共享。
Gigascience. 2013 May 1;2(1):7. doi: 10.1186/2047-217X-2-7.
5
Open data sharing in the context of bioresources.生物资源背景下的开放数据共享。
Acta Inform Med. 2013 Dec;21(4):291-2. doi: 10.5455/aim.2013.21.291-292. Epub 2013 Dec 4.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.克罗地亚皮肤性病学会史——克罗地亚医学协会及《克罗地亚皮肤性病学学报》重要信息概述
Acta Dermatovenerol Croat. 2018 Dec;26(4):344-348.
8
Meta-analysis: Problems with Russian Publications.荟萃分析:俄罗斯出版物存在的问题。
Int J Risk Saf Med. 2015;27 Suppl 1:S89-90. doi: 10.3233/JRS-150702.
9
The National Institutes of Health and guidance for reporting preclinical research.美国国立卫生研究院与临床前研究报告指南。
BMC Med. 2015 Feb 17;13:34. doi: 10.1186/s12916-015-0284-9.
10
Impact Factors and Prediction of Popular Topics in a Journal.期刊中热门话题的影响因素及预测
Ultraschall Med. 2016 Aug;37(4):343-5. doi: 10.1055/s-0042-111209. Epub 2016 Aug 4.

引用本文的文献

1
Quantifying the impact of biobanks and cohort studies.量化生物样本库和队列研究的影响。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2427157122. doi: 10.1073/pnas.2427157122. Epub 2025 Apr 16.
2
An overview of Synlab SDN Biobank's quality control system.概述 Synlab SDN 生物库的质量控制系统。
Sci Rep. 2024 Aug 20;14(1):19303. doi: 10.1038/s41598-024-70263-3.
3
Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine.生物样本库综合管理的数据模型及其对个性化医疗的贡献。
J Pers Med. 2024 Jun 21;14(7):668. doi: 10.3390/jpm14070668.
4
TAD boundary deletion causes PITX2-related cardiac electrical and structural defects.TAD 边界缺失导致与 PITX2 相关的心脏电和结构缺陷。
Nat Commun. 2024 Apr 20;15(1):3380. doi: 10.1038/s41467-024-47739-x.
5
Burden of rare variants in arrhythmogenic cardiomyopathy with right dominant form-associated genes provides new insights for molecular diagnosis and clinical management.右优势型心律失常性右室心肌病相关基因的罕见变异负担为分子诊断和临床管理提供了新的见解。
Hum Mutat. 2022 Sep;43(9):1333-1342. doi: 10.1002/humu.24436. Epub 2022 Jul 23.
6
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility.全基因组关联分析鉴定出布加综合征的新风险位点,并强调了钠离子通道调节疾病易感性的新机制。
Nat Genet. 2022 Mar;54(3):232-239. doi: 10.1038/s41588-021-01007-6. Epub 2022 Feb 24.
7
Basic principles of biobanking: from biological samples to precision medicine for patients.生物样本库的基本原则:从生物样本到患者的精准医疗。
Virchows Arch. 2021 Aug;479(2):233-246. doi: 10.1007/s00428-021-03151-0. Epub 2021 Jul 13.
8
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.独特的免疫学特征可区分 COVID-19 重症与非 SARS-CoV-2 驱动的重症肺炎。
Immunity. 2021 Jul 13;54(7):1578-1593.e5. doi: 10.1016/j.immuni.2021.05.002. Epub 2021 May 9.
9
A systematic literature review of researchers' and healthcare professionals' attitudes towards the secondary use and sharing of health administrative and clinical trial data.对研究人员和医疗保健专业人员对健康管理和临床试验数据的二次使用和共享的态度的系统文献回顾。
Syst Rev. 2020 Oct 12;9(1):240. doi: 10.1186/s13643-020-01485-5.
10
Improving transparency and scientific rigor in academic publishing.提高学术出版的透明度和科学严谨性。
Cancer Rep (Hoboken). 2019 Feb;2(1):e1150. doi: 10.1002/cnr2.1150. Epub 2018 Dec 2.

本文引用的文献

1
Recommendations for the role of publishers in access to data.关于出版商在数据获取方面作用的建议。
PLoS Biol. 2014 Oct 28;12(10):e1001975. doi: 10.1371/journal.pbio.1001975. eCollection 2014 Oct.
2
EASE Guidelines for Authors and Translators of Scientific Articles to be Published in English.《英文发表科学文章的作者和译者易用指南》
Acta Inform Med. 2014 Jun;22(3):210-7. doi: 10.5455/aim.2014.22.210-217. Epub 2014 Jun 15.
3
The European Research Infrastructures of the ESFRI Roadmap in Biological and Medical Sciences: status and perspectives.欧洲研究基础设施组织在生物和医学科学领域的 ESFRI 路线图:现状与展望。
Ann Ist Super Sanita. 2014;50(2):178-85. doi: 10.4415/ANN_14_02_12.
4
Open data sharing in the context of bioresources.生物资源背景下的开放数据共享。
Acta Inform Med. 2013 Dec;21(4):291-2. doi: 10.5455/aim.2013.21.291-292. Epub 2013 Dec 4.
5
Proposal for a data publication and citation framework when sharing biomedical research resources.共享生物医学研究资源时的数据发表与引用框架提案。
Stud Health Technol Inform. 2013;192:1201.
6
Quantifying the use of bioresources for promoting their sharing in scientific research.量化生物资源的使用,以促进其在科学研究中的共享。
Gigascience. 2013 May 1;2(1):7. doi: 10.1186/2047-217X-2-7.
7
Ushering in a new era of open science through data sharing: the wall must come down.通过数据共享迎来开放科学的新时代:必须推倒这堵墙。
JAMA. 2013 Apr 3;309(13):1355-6. doi: 10.1001/jama.2013.1299.
8
More quality measures versus measuring what matters: a call for balance and parsimony.更多的质量措施与衡量重要事项:呼吁平衡和简约。
BMJ Qual Saf. 2012 Nov;21(11):964-8. doi: 10.1136/bmjqs-2012-001081. Epub 2012 Aug 14.
9
The importance of clinical trial data sharing: toward more open science.临床试验数据共享的重要性:迈向更开放的科学。
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):238-40. doi: 10.1161/CIRCOUTCOMES.112.965798.
10
Better provenance for biobank samples.生物样本库样本更可靠的来源。
Nature. 2011 Jul 27;475(7357):454-5. doi: 10.1038/475454d.